Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance-Reference-Cited by-同舟云学术

Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance

Published:2014-02-24 Issue:4 Volume:124 Page:1810-1820
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Jandus Camilla,Boligan Kayluz Frias,Chijioke Obinna,Liu He,Dahlhaus Meike,Démoulins Thomas,Schneider Christoph,Wehrli Marc,Hunger Robert E.,Baerlocher Gabriela M.,Simon Hans-Uwe,Romero Pedro,Münz Christian,von Gunten Stephan

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference54 articles.

1. Diversity in cell surface sialic acid presentations: implications for biology and disease

2. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: Clues in the ongoing search for new tumor markers

3. Tumour-associated carbohydrate antigens in breast cancer

4. The sweet and sour of cancer: glycans as novel therapeutic targets

Cited by 339 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Siglec7 functions as an inhibitory receptor of non-specific cytotoxic cells and can regulate the innate immune responses in a primitive vertebrate (Oreochromis niloticus);International Journal of Biological Macromolecules;2024-10

2. Siglec‐7 and Siglec‐9 expression in primary triple negative and oestrogen receptor positive breast cancer and in vitro signalling;Clinical & Translational Immunology;2024-09

3. Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy;Journal for ImmunoTherapy of Cancer;2024-08

4. Glycosylation and Its Role in Immune Checkpoint Proteins: From Molecular Mechanisms to Clinical Implications;Biomedicines;2024-06-28

5. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review;Frontiers in Oncology;2024-06-07